BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

curasan AG (DX:CUR) Now Sells Bone Regeneration Material in Injectable Form


12/5/2012 11:45:37 AM

Kleinostheim, 05.12.2012 - curasan AG, listed on the General Standard (ISIN: DE 000 549 453 8), has introduced its new bone regeneration material CERASORB® Ortho Paste to the German and European markets at the beginning of December.

CERASORB® Ortho Paste is comprised of fine granules of the proven, fully resorbable, synthetic material CERASORB® M Ortho suspended in a hyaluronic acid hydrogel-matrix. The paste-like product has the advantage that it is pre-packaged in a single-use syringe and does not require any mixing or complicated preparation in order to be applied to the bone defect.

The paste serves as a place holder in the defect and provides ideal conditions for the ingrowth of blood vessels. At the same time, the hydrogel structure of the hyaluronic acid supports the metabolism for new bone generation. In this way new bone grows at the interface with the surrounding healthy bone as the CERASORB® Ortho Paste is resorbed.

The new product, for which a patent has been filed, is expected to be used mainly for filling smaller defects, for example in hand and foot surgery, for smaller bone cysts, for filling of spinal cages, and for minimally invasive sinus lift procedures.

"From the side of the orthopedic and trauma surgeons, there is a strong interest in simple and easy to use materials, particularly for difficult to reach defects", commented Hans-Dieter Rössler, CEO of curasan AG. "We can now fulfill this wish with our latest development."



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES